ICG Fluorescence Imaging in Post-traumatic Infection

Active, not recruitingOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Trauma Injury
Interventions
OTHER

Immunofluorescence Imaging

Patients will be administered FDA approved ICG through intravenous injection and imaged by a FDA approved surgical microscope (Spy Elite) which is 0.5 meter away from the subject. Both ICG fluorescence and the two imaging systems have been used for routine clinical practice for many years. Figure (a) shows the Schematic sketch of the imaging systems. ICG fluorescence imaging utilizes intravenously injected ICG, which is a fluorescent dye that is FDA-approved for clinical use, illuminated with near-infrared light. The ICG dye is indirectly activated and the dynamic fluorescence due to bone perfusion can be captured by a video rate imaging system.

OTHER

DCE-MRI

Characterize the relationship between bone perfusion as quantified by ICG based DCE-FI and DCE-MRI in human patients to develop an accurate depth-sensitive fluorescence imaging model that will correct for the surface-weighted feature of fluorescence imaging

Trial Locations (4)

21201

University of Maryland, Baltimore R. Adams Cowley Shock Trauma, Baltimore

92614

University of California, Irvine, Irvine

02115

Brigham and Women's Hospital, Boston

03756

Dartmouth Hitchcock Medical Center, Lebanon

All Listed Sponsors
collaborator

Dartmouth College

OTHER

collaborator

University of Maryland, Baltimore

OTHER

collaborator

University of California, Irvine

OTHER

lead

Dartmouth-Hitchcock Medical Center

OTHER